8
Oxidative Medicine and Cellular Longevity
Bioorganic & Medicinal Chemistry, vol. 13, no. 7, pp. 2355–
2372, 2005.
determination of rate constants for reactions of hydroxyl rad-
icals,” Analytical Biochemistry, vol. 165, no. 1, pp. 215–219,
1987.
[31] Y.-H. Kong, L. Zhang, Z.-Y. Yang et al., “Natural product
juglone targets three key enzymes from Helicobacter pylori:
inhibition assay with crystal structure characterization,” Acta
Pharmacologica Sinica, vol. 29, no. 7, pp. 870–876, 2008.
[46] B. Julio, C. Michael, M. Luis et al., “Green synthetic approaches
to furoylnaphthohydroquinone and juglone,” Journal of the
Chilean Chemical Society, vol. 59, no. 2, pp. 2455–2457, 2014.
[32] H. R. Nasiri, M. G. Madej, R. Panisch et al., “Design, synthesis,
and biological testing of novel naphthoquinones as substrate-
based inhibitors of the quinol/fumarate reductase from Woli-
nella succinogenes,” Journal of Medicinal Chemistry, vol. 56,
no. 23, pp. 9530–9541, 2013.
[47] D. Bhasin, S. N. Chettiar, J. P. Etter, M. Mok, and P. K. Li,
“Anticancer activity and SAR studies of substituted 1,4-
naphthoquinones,” Bioorganic
& Medicinal Chemistry,
vol. 21, no. 15, pp. 4662–4669, 2013.
[48] L. I. Lopez-Lopez, J. J. Vaquera Garcia, A. Saenz-Galindo, and
S. Y. Silva-Belmares, “Ultrasonic and microwave assisted syn-
thesis of nitrogen-containing derivatives of juglone as poten-
tial antibacterial agents,” Letters in Organic Chemistry,
vol. 11, no. 8, pp. 573–582, 2014.
[33] Y. C. Wang and Y. H. Lin, “Anti-gastric adenocarcinoma
activity of 2-methoxy-1,4-naphthoquinone, an anti-Helicobac-
ter pylori compound from Impatiens balsamina L,” Fitoterapia,
vol. 83, no. 8, pp. 1336–1344, 2012.
[34] S. Skouloubris, K. Djaout, I. Lamarre et al., “Targeting of Heli-
cobacter pylori thymidylate synthase ThyX by non-mitotoxic
hydroxy-naphthoquinones,” Open Biology, vol. 5, no. 6, article
150015, 2015.
[49] M. D. Coleman, “Dapsone: modes of action, toxicity and pos-
sible strategies for increasing patient tolerance,” British Journal
of Dermatology, vol. 129, no. 5, pp. 507–513, 1993.
[50] C. Bonacorsi, M. S. G. Raddi, I. Z. Carlos, M. Sannomiya, and
W. Vilegas, “Anti-Helicobacter pylori activity and immunosti-
mulatory effect of extracts from Byrsonima crassa Nied. (Mal-
pighiaceae),” BMC Complementary and Alternative Medicine,
vol. 9, no. 1, pp. 1–7, 2009.
[35] Y. Prieto, M. Muñoz, V. Arancibia, M. Valderrama, F. J. Lahoz,
and M. Luisa Martín, “Synthesis, structure and properties of
ruthenium(II) complexes with quinolinedione derivatives as
chelate ligands: crystal structure of [Ru(CO)2Cl2(6-methoxy-
benzo[g]quinoline-5,10-dione)],” Polyhedron, vol. 26, no. 18,
pp. 5527–5532, 2007.
[51] S. Chaves, M. Gadanho, R. Tenreiro, and J. Cabrita, “Assess-
ment of metronidazole susceptibility in Helicobacter pylori:
statistical validation and error rate analysis of breakpoints
determined by the disk diffusion test,” Journal of Clinical
Microbiology, vol. 37, no. 5, pp. 1628–1631, 1999.
[36] T. Mukherjee, “One-electron reduction of juglone (5-hydroxy-
1,4-naphthoquinone): a pulse radiolysis study,” International
Journal of Radiation Applications and Instrumentation. Part
C. Radiation Physics and Chemistry, vol. 29, no. 6, pp. 455–
462, 1987.
[52] L. Lang and F. Garcia, “Comparison of E-test and disk diffu-
sion assay to evaluate resistance of Helicobacter pylori isolates
to amoxicillin, clarithromycin, metronidazole and tetracycline
in Costa Rica,” International Journal of Antimicrobial Agents,
vol. 24, no. 6, pp. 572–577, 2004.
[37] P. Wardman, “Reduction potentials of one-electron couples
involving free radicals in aqueous solution,” Journal of Physical
and Chemical Reference Data, vol. 18, no. 4, pp. 1637–1755,
1989.
[53] J. I. Smith, B. Drumm, A. W. Neumann, Z. Policova, and P. M.
Sherman, “In vitro surface properties of the newly recognized
gastric pathogen Helicobacter pylori,” Infection and Immunity,
vol. 58, no. 9, pp. 3056–3060, 1990.
[38] H. Toledo, M. Valenzuela, A. Rivas, and C. A. Jerez, “Acid
stress response in Helicobacter pylori,” FEMS Microbiology
Letters, vol. 213, no. 1, pp. 67–72, 2002.
[39] O. Cerda, A. Rivas, and H. Toledo, “Helicobacter pylori strain
ATCC700392 encodes a methyl-accepting chemotaxis recep-
tor protein (MCP) for arginine and sodium bicarbonate,”
FEMS Microbiology Letters, vol. 224, no. 2, pp. 175–181, 2003.
[54] F. C. Abreu, P. A. L. Ferraz, and M. O. F. Goulart, “Some appli-
cations of electrochemistry in biomedical chemistry. emphasis
on the correlation of electrochemical and bioactive proper-
ties,” Journal of the Brazilian Chemical Society, vol. 13, no. 1,
pp. 19–35, 2002.
[40] H. Toledo and R. López-Solís, “Tetracycline resistance in Chil-
ean clinical isolates of Helicobacter pylori,” Journal of Antimi-
crobial Chemotherapy, vol. 65, no. 3, pp. 470–473, 2010.
[55] M. Aguilar-Martinez, G. Cuevas, M. Jimenez-Estrada,
I. Gonzalez, B. Lotina Hennsen, and M. Macias-Ruvalcaba,
“An experimental and theoretical study of the substituent
effects on the redox properties of 2-[(R-phenyl)amine]-1,4-
naphthalenediones in acetonitrile,” The Journal of Organic
Chemistry, vol. 64, no. 10, pp. 3684–3694, 1999.
[41] K. A. Stevens, B. W. Sheldon, N. A. Klapes, and T. R. Klaen-
hammer, “Nisin treatment for inactivation of Salmonella spe-
cies and other gram-negative bacteria,” Applied and
Environmental Microbiology, vol. 57, no. 12, pp. 3613–3615,
1991.
[56] A. Rahmani, G. Abangah, A. Moradkhani, M. R. Hafezi
Ahmadi, and K. Asadollahi, “Coenzyme Q10 in combination
with triple therapy regimens ameliorates oxidative stress and
lipid peroxidation in chronic gastritis associated with H. Pylori
infection,” Journal of Clinical Pharmacology, vol. 55, no. 8,
pp. 842–847, 2015.
[42] R. Díaz-Gómez, R. López-Solís, E. Obreque-Slier, and
H. Toledo-Araya, “Comparative antibacterial effect of gallic
acid and catechin against Helicobacter pylori,” LWT - Food Sci-
ence and Technology, vol. 54, no. 2, pp. 331–335, 2013.
[43] I. A. Eydelnant and N. Tufenkji, “Cranberry derived proantho-
cyanidins reduce bacterial adhesion to selected biomaterials,”
Langmuir, vol. 24, no. 18, pp. 10273–10281, 2008.
[44] M. J. Rodríguez Vaquero, M. R. Alberto, and M. C. Manca de
Nadra, “Antibacterial effect of phenolic compounds from dif-
ferent wines,” Food Control, vol. 18, no. 2, pp. 93–101, 2007.
[45] B. Halliwell, J. M. C. Gutteridge, and O. I. Aruoma, “The
deoxyribose method:
a simple “test-tube” assay for